1. Home
  2. HALO vs DLB Comparison

HALO vs DLB Comparison

Compare HALO & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • DLB
  • Stock Information
  • Founded
  • HALO 1998
  • DLB 1965
  • Country
  • HALO United States
  • DLB United States
  • Employees
  • HALO N/A
  • DLB N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • DLB Multi-Sector Companies
  • Sector
  • HALO Health Care
  • DLB Miscellaneous
  • Exchange
  • HALO Nasdaq
  • DLB Nasdaq
  • Market Cap
  • HALO 7.4B
  • DLB 7.9B
  • IPO Year
  • HALO N/A
  • DLB 2005
  • Fundamental
  • Price
  • HALO $52.02
  • DLB $77.57
  • Analyst Decision
  • HALO Buy
  • DLB Strong Buy
  • Analyst Count
  • HALO 9
  • DLB 4
  • Target Price
  • HALO $63.56
  • DLB $101.75
  • AVG Volume (30 Days)
  • HALO 3.1M
  • DLB 400.0K
  • Earning Date
  • HALO 05-06-2025
  • DLB 05-01-2025
  • Dividend Yield
  • HALO N/A
  • DLB 1.71%
  • EPS Growth
  • HALO 55.40
  • DLB 36.08
  • EPS
  • HALO 3.76
  • DLB 2.64
  • Revenue
  • HALO $1,084,306,000.00
  • DLB $1,320,184,000.00
  • Revenue This Year
  • HALO $24.79
  • DLB $6.38
  • Revenue Next Year
  • HALO $22.65
  • DLB $4.65
  • P/E Ratio
  • HALO $13.83
  • DLB $29.29
  • Revenue Growth
  • HALO 25.64
  • DLB 4.03
  • 52 Week Low
  • HALO $41.28
  • DLB $66.35
  • 52 Week High
  • HALO $70.51
  • DLB $89.66
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • DLB 56.62
  • Support Level
  • HALO $47.50
  • DLB $76.69
  • Resistance Level
  • HALO $69.94
  • DLB $78.28
  • Average True Range (ATR)
  • HALO 3.52
  • DLB 1.39
  • MACD
  • HALO -1.49
  • DLB 0.47
  • Stochastic Oscillator
  • HALO 19.64
  • DLB 88.03

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About DLB Dolby Laboratories

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.

Share on Social Networks: